GREENVILLE, S.C. — [10.21.26] — Tribe Clinical Research (TCR) is pleased to announce the launch of its first clinical research study in partnership with Greenville Ear, Nose and Throat (ENT), marking an important milestone in the organizations' shared commitment to expanding access to clinical research opportunities across the Upstate.
GREENVILLE, S.C. — [10.21.26] — Tribe Clinical Research (TCR) is pleased to announce a new clinical research partnership with Gastroenterology Associates, expanding access to innovative clinical trial opportunities for patients across Upstate South Carolina.
GREENVILLE, S.C. —This week, a new clinical trial is starting in the Upstate for a new-generation flu vaccine that's being studied by GSK. They are starting their Phase III efficacy trial in partnership with Greenville-based Tribe Clinical Research.
Dr. Scott Dobson is the Medical Director at Tribe and has been a practicing pediatrician for more than two decades. He says the new vaccine is "specific for adults 65 and up and will be compared to an existing flu vaccine that's already available. So it's not a placebo trial, which is great for patients."
Many people ages 65 and up in Greenville and Spartanburg may have received postcards in the mail inviting them to participate in the trial.
Health information can feel overwhelming. Medical terms, test results, treatment options, medications, and online advice can make it difficult to know where to begin. Health Literacy Month is a reminder that everyone deserves clear, understandable information to help them make informed decisions about their care.
August is National Immunization Awareness Month, a time to recognize the important role vaccines play in protecting individuals, families, and communities from preventable illnesses.
Vaccines are one of the most effective tools available to help reduce the spread and severity of infectious diseases.